| Literature DB >> 27865282 |
George Younan1, Susan Tsai1, Douglas B Evans1, Kathleen K Christians2.
Abstract
Multimodality therapy has become the standard approach for the treatment of pancreatic cancer. With improved response rates to newer chemotherapeutic agents, tumors that used to be considered unresectable are now being considered for operation. Neoadjuvant therapy for borderline resectable pancreatic cancer is considered standard of care and venous resection/reconstruction is no longer controversial. Arterial resection and reconstruction in select patients has also proven to be safe when done in highly specialized centers by high-volume surgeons. This article reviews indications for, and technical aspects of, vascular resection/reconstruction and shunting procedures during pancreatectomy, including critical elements of perioperative care.Entities:
Keywords: Pancreaticoduodenectomy; Vascular reconstruction; Vascular resection; Whipple
Mesh:
Year: 2016 PMID: 27865282 DOI: 10.1016/j.suc.2016.07.005
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741